Background. It has been hypothesized that chemotaxis and activation of polymorphonuclear leukocytes (PMNs) occur upon reperfusion of ischemic myocardium. Questions remain, however, regarding the mechanisms by which PMNs are chemotaxed and activated and how this process causes contractile failure.
P olymorphonuclear leukocytes (PMNs) have been hypothesized to either cause or amplify the process of reperfusion injury in postischemic myocardium. It has been suggested that PMNs mediate reperfusion injury by chemotaxis and activation with the generation of oxygen free radicals and the release of proteolytic enzymes and other toxic products. In addition, they also release various inflammatory and chemotactic mediators that can result in a cycle of further cellular chemotaxis and injury.1 There is increasing evidence that within reperfused myocardial tissue there is extensive margination of PMNs and capillary plugging of the coronary microvasculature, which subsequently leads to extensive myocardial damage.2-4 Several studies have demonstrated that PMN depletion can decrease infarct size and prevent myocardial stunning.5 There is recent evidence that plasma factors including complement may be involved in the process of PMN activation. 6, 7 With in vivo models, there are many different cellular and humoral factors that cannot be controlled; thus, it is often difficult to definitively determine the importance of isolated cellular or humoral factors in the pathogenesis of myocardial injury. Therefore, we Coronary flow and heart rates were measured periodically every 5 minutes before 20-minute global ischemia and after global ischemia for 45 minutes of reperfusion.
PMN Preparation
Human neutrophils were prepared by the method of Kensler and Trush,9 which yields PMNs with a purity of >95%. Freshly sampled blood (50 ml) was drawn from volunteer donors in heparinized 10-ml vacuum containers and centrifuged at SOOg in a Beckman TJ-6 for 10 minutes. The plasma and buffy coat were aspirated, leaving the red cell layer. The cells were then mixed with an equal volume of 6% dextran (1 g dextran MW 500,000, 5 g dextran MW 80,000, and 100 ml 0.9% normal saline), with the tubes rinsed thoroughly to secure all the cells. The mixture was then transferred to 30-ml plastic syringes, which were then inverted and incubated at 370C for 1 hour until a clear separation was obtained. Next, the upper layer was ejected through a 16-gauge needle with a 900 bend into 50-mi plastic centrifuge tubes and spun for 10 minutes at 500g. The supernatant was discarded, and the pellet was resuspended in ice-cold ACK lysing buffer (0.155 M NH4Cl, 0.01 M KHCO3, and 0.1 mM EDTA at pH 7.4) and respun for 10 minutes at 500g. Finally, the pellet was washed, resuspended in Dulbecco's phosphate-buffered saline (PBS) with 1% glucose, and spun for 5 minutes at 340g. A small volume of the cells resuspended in Dulbecco's was counted with a hemocytometer.
Rat Plasma
Rat blood obtained by closed-chest intracardiac puncture with a 10-ml heparinized syringe was immediately centrifuged at 500g. To denature complement, the upper plasma layer was subsequently transferred to a plastic centrifuge tube and incubated in a water bath at 56WC for 45 minutes. 10 
Electron Paramagnetic Resonance Measurements
Hearts were isolated and perfused as described above except that no EDTA was included in the perfusate. The experimental protocol remained the same except that the spin trap 5,5'-dimethyl-1-pyrroline-N-oxide (DMPO) was infused through a third side arm located at the level of the heart with a final concentration of 40 mM. Periodic collections of the effluent were made in 20-second aliquots during the control period and also for the first 2, 5, 7.5, and 10 minutes of reperfusion. In addition, experiments were performed to detect the generation of oxygen free radicals in PMNs plus plasma with and without zymosan, an activator of complement." Care was taken to keep the DMPO-containing solutions covered to prevent any light-induced degradation. The DMPO purchased from Aldrich was further purified by double distillation.
Electron paramagnetic resonance (EPR) spectra were recorded in an EPR flat cell at room temperature with a Bruker-IBM ER 300 spectrometer operating at X-band using a TM11o cavity, a modulation frequency of 100 kHz, modulation amplitude of 0.5 G, microwave power of 20 mWatts, and microwave frequency of 9.77 GHz. Each spectral acquisition file was the sum of ten 1-minute scans. The digital Bruker spectral data were transferred to an AST 386 personal computer for analysis. Software capable of isotropic spectral simulation, developed in this laboratory, was used for component analysis of experimental spectra as described previously.12-'4 Spectral simulations consisting of linear combinations of the component signals were performed to match the observed spectra. From the weighted intensities of each component in these simulations, the relative amount of each component signal was determined. The total radical concentration was then determined from the ratio of the double integral of the observed spectra to the known concentration of 2,2,6,6-tetramethylpiperidinoxy free radical in aqueous solution as previously described.12,14
Histology
After completion of the experiments, hearts were quickly removed from the cannula, and the ventricles were sliced into sections 3-5 mm thick. The sections were immediately immersed and stored in 10% formalin tional methods. Sections were stained with hematoxylin and eosin. The histological sections were examined for the extent of PMN infiltration in myocardial interstitium and around the capillaries and arterioles.
Measurement of Complement Activation
Measurement of complement activation by red cell lysis assay was performed to determine whether the mixture of human PMNs and rat plasma caused any nonspecific activation of complement. In these assays, 0.4 ml of the PMN-containing buffer and 0.1 ml plasma were added to 0.5 ml packed human blood cells and incubated at 37°C for 30 minutes. The red blood cells were then pelleted by centrifugation at 500g for 5 minutes. Spectrophotometric measurements of hemoglobin in the supernatant solution were then performed. No hemolysis was observed when the PMNs and plasma were mixed, which demonstrated that there was no nonspecific complement activation. On addition of the complement activator zymosan, 1 mg/ml, however, marked hemolysis was observed.
Chemicals
Recombinant C5a, zymosan A, and bovine copperzinc superoxide dismutase were purchased from Sigma Chemical Co., St. Louis, Mo. Double-distilled, deionized water was used to prepare the perfusate and other solutions.
DMPO, 97% pure, was purchased from Aldrich Chemical Co. and further purified by double distillation.
Experimental Protocol
After a 10-15-minute equilibration period, baseline LVDP, left ventricular end-diastolic pressure, and coronary flow were measured ( Figure 1 , bottom panel). Hearts were then subjected to a 1-minute preischemic control infusion with PMNs alone, plasma alone, PMNs and plasma, or PMNs and inactivated plasma, and then hearts were allowed to equilibrate again with Krebs bicarbonate buffer for a period of 10 minutes, during which time measurements of coronary flow and LVDP were noted. Hearts subsequently received a 30-second infusion of one of the requisite media before the onset of the 20-minute period of 37°C global ischemia. At the onset of ischemia, the balloon was deflated. The intraventricular balloon volume was then reinflated with the same volume as previously used to set the baseline end-diastolic pressure immediately after the onset of reflow. At the onset of reperfusion, the hearts were reperfused for the first 5 minutes with the requisite media for each of five different groups, after which perfusion was continued with Krebs buffer alone for a total of 45 minutes of reflow, during which time serial measurements of coronary flow and LVDP were performed every 5 minutes. One or more side-arm ports were placed just above the aortic cannula to allow administration of cells, plasma, or both ( Figure 1 ). To determine free-radical generation, hearts were similarly perfused in each of the groups in the presence of 40 mM DMPO as described above, but without EDTA in the perfusate.
Five experimental groups were studied, with .ccumulation.
induce any activation of complement, red cell lysis tp 3. Hearts were reperfused with perfusate conassays were performed as described above. These assays rat plasma alone at 1:20 dilution.
demonstrated that mixture of human PMNs and rat tp 4. Hearts were reperfused with perfusate conplasma did not result in any measurable complement both PMNs and plasma. PMNs were infused as activation. If complement was intentionally activated ted in Group 2, and rat plasma was similarly with 1 mg/ml of zymosan, however, marked red cell lysis at a 1:20 dilution. The effluent was collected to and marked free-radical generation was observed. te the percent of PMN accumulation.
Thus, these validation experiments demonstrated that p 5. Hearts were reperfused with 300,000 PMNs there was no baseline complement activation, neutroliliter plus inactivated rat plasma. Rate-pressure product. The product of heart rate and LVDP, the rate-pressure product, was measured as a further index of cardiac work, and a dependence similar to that for LVDP alone was observed. The group 4 hearts exhibited a markedly lower rate-pressure product than the other groups throughout reflow. Approximately a twofold difference was observed between the recovery of rate-pressure product between group 4 and with that observed with buffer alone. Thus, with PMNs and plasma resulted in a mark tion in the duration of radical generation.
Effects of CSa and Activated Plasma on ( Function and Radical Generation
In the above-described studies, we ot increased myocardial injury was observed EPR studies were performed with 106 PMNs per milliliter in the presence of 50 mM DMPO and 5 vol% of zymosan-activated plasma or various concentrations of C5a. With control PMNs, no detectable EPR signal was seen, whereas with 5% zymosan-activated plasma, a prominent 1: 2: 2:1 quartet signal with hyperfine coupling constants aN=aH= 14.9 G indicative of DMPO-OH and a smaller signal of DMPO-OOH (Figure 10 ). Both of these signals were quenched in the presence of 100 500 600 units/ml of superoxide dismutase, indicating that both signals were derived from the superoxide free radical.
concentration With CSa, prominent free-radical signals were also seen. voline-N-oxide As shown in Figure 10 , with 500 ng/ml of CSa, a clear ? spectroscopy 1 In the present study, we noted that when hearts were reperfused in the presence of both PMNs and plasma, the magnitude of free-radical generation was amplified and the duration was considerably increased from that observed in hearts reperfused in the absence of PMNs. This increased free-radical generation was associated with the subsequent markedly increased failure of cardiac contractile function. These results are consistent with the large number of studies that have demonstrated that reperfusion injury is partly caused by freeradical generation. In these studies, it has been shown that free-radical-scavenging compounds or enzymes can decrease infarct size and prevent myocardial stunning.8, [21] [22] [23] [24] [25] In postischemic hearts, PMN accumulation within the heart was increased twofold to threefold compared with that observed before ischemia. This increased PMN accumulation was observed in the presence or absence of plasma, indicating that PMN accumulation was independent of plasma factors. However, EPR studies of free-radical generation demonstrated that plasma factors were necessary to observe PMN activation with the generation of an oxidant burst. Histological studies showed that PMNs adhere to arteriole and capillary endothelium in the absence of plasma factors; however, in the presence of plasma, PMNs egress out to the myocytes, inducing myocyte injury. In the presence of plasma, PMNs were observed to be degranulating adjacent to myocytes, with myocyte necrosis and disruption of myofibrillar structure. Since PMN adherence is thought to be caused primarily by specific binding of adhesion molecule receptors, these data may suggest that independent of complement activation, adhesion molecules such as ICAM on the endothelial cell or CD-18 on the PMN are upregulated during ischemia and early reperfusion. In the presence of the chemotactic stimulation of activated complement, PMN migration out of the vasculature into the tissue may occur.
It has been suggested by Ito et a126 that complement activation alone may cause a significant degree of myocardial dysfunction. They have observed that infusion of C5a into the coronary arteries of pigs can result in marked contractile dysfunction and can exacerbate ischemic injury. Therefore, we investigated the effects of activated complement, C5a, or zymosan-activated plasma. With either 500 ng/ml of CSa or 5 vol% of zymosan-activated plasma, prominent PMN activation was observed, with measurable free-radical generation. Infusion of CSa alone did not induce significant injury compared with the control group, group 1. In the presence of PMNs in addition to CSa, marked injury was observed. Since C5a resulted in PMN-mediated injury identical to that with whole plasma, these experiments suggest that the plasma factor required for PMN activation is CSa. Additional experiments in which complement was activated with zymosan to maximally activate the full complement cascade were performed and also demonstrated that the activated complement alone was not sufficient in itself to induce significant contractile failure but was sufficient in the presence of PMNs. These studies demonstrate that complement activation, although not sufficient in itself to increase postischemic injury, is sufficient to activate free-radical generation by PMNs, which in turn causes marked injury.
In summary, these studies demonstrate that PMNs in the presence of plasma can markedly amplify reperfusion injury, resulting in marked contractile failure, increased free-radical generation, and increased histological damage. The plasma factors required for PMN activation appear to be primarily complement, with C5a effectively able to substitute for whole plasma. Thus, we observe that complement is required for PMN activation in the postischemic heart with the generation of an oxidative burst and subsequent myocardial injury.
